Hypertension, Blood Pressure Variability, and Target Organ Lesion

Imagem de Miniatura
Arquivos
art_IRIGOYEN_Hypertension_Blood_Pressure_Variability_and_Target_Organ_Lesion_2016.PDF (490.02 KB)
Citações na Scopus
57
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
ANGELIS, Katia De
DARTORA, Daniela R.
RODRIGUES, Bruno
Citação
CURRENT HYPERTENSION REPORTS, v.18, n.4, article ID 31, 13p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Hypertensive patients have a higher risk of developing health complications, particularly cardiovascular (CV) events, than individuals with normal blood pressure (BP). Severity of complications depends on the magnitude of BP elevation and other CV risk factors associated with the target organ damage. Therefore, BP control and management of organ damage may contribute to reduce this risk. BP variability (BPV) has been considered a physiological marker of autonomic nervous system control and may be implicated in increased CV risk in hypertension. This review will present some evidence relating BPV and target organ damage in hypertension in clinical and experimental settings.
Palavras-chave
Hypertension, Autonomic dysfunction, Blood pressure variability, Target-organ damage
URI
https://observatorio.fm.usp.br/handle/OPI/14053
Referências
  1. Dolan E, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0649-x
  2. IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111
  3. Mancia G, 2012, J HYPERTENS, V30, P1241, DOI 10.1097/HJH.0b013e32835339ac
  4. Brickman AM, 2010, ARCH NEUROL-CHICAGO, V67, P564, DOI 10.1001/archneurol.2010.70
  5. Martinka P, 2005, AM J PHYSIOL-REG I, V288, pR767, DOI 10.1152/ajpregu.00445.2004
  6. Tsioufis C, 2011, AM J NEPHROL, V33, P277, DOI 10.1159/000324697
  7. Flues K, 2012, AUTON NEUROSCI-BASIC, V166, P47, DOI 10.1016/j.autneu.2011.10.005
  8. Leoncini G, 2013, J HUM HYPERTENS, V27, P663, DOI 10.1038/jhh.2013.45
  9. Yu JM, 2014, INT J CARDIOL, V177, P995, DOI 10.1016/j.ijcard.2014.09.149
  10. Ling G, 2007, ACTA PHARMACOL SIN, V28, P1755, DOI 10.1111/j.1745-7254.2007.00630.x
  11. Sueta D, 2014, ATHEROSCLEROSIS, V236, P101, DOI 10.1016/j.atherosclerosis.2014.06.016
  12. Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903
  13. Kawai T, 2012, HYPERTENS RES, V35, P239, DOI 10.1038/hr.2011.170
  14. Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128
  15. Mancia G, 1997, CIRCULATION, V95, P1464
  16. Han P, 2009, J CELL MOL MED, V13, P726, DOI 10.1111/j.1582-4934.2008.00365.x
  17. Zakopoulos NA, 2005, HYPERTENSION, V45, P505, DOI 10.1161/01.HYP.0000158306.87582.43
  18. Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657
  19. Metoki H, 2006, HYPERTENSION, V47, P149, DOI 10.1161/01.HYP.0000198541.12640.0f
  20. Nagai M, 2015, GERIATR GERONTOL INT, V15, P26, DOI 10.1111/ggi.12660
  21. Wei FF, 2014, HYPERTENSION, V63, P790, DOI 10.1161/HYPERTENSIONAHA.113.02681
  22. Tatasciore A, 2013, J HYPERTENS, V31, P1653, DOI 10.1097/HJH.0b013e328361e4a6
  23. Grassi G, 2012, CURR HYPERTENS REP, V14, P333, DOI 10.1007/s11906-012-0273-8
  24. Hashimoto T, 2012, AM J HYPERTENS, V25, P883, DOI 10.1038/ajh.2012.62
  25. Madden JM, 2015, J HUM HYPERTENS, V29, P719, DOI 10.1038/jhh.2015.18
  26. Masugata H, 2011, HYPERTENS RES, V34, P846, DOI 10.1038/hr.2011.54
  27. Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273
  28. Zhang Y, 2011, HYPERTENSION, V58, P155, DOI 10.1161/HYPERTENSIONAHA.111.174383
  29. Okada T, 2012, BLOOD PRESS MONIT, V17, P1, DOI 10.1097/MBP.0b013e32834f7125
  30. Bertagnolli M, 2008, AM J HYPERTENS, V21, P1188, DOI 10.1038/ajh.2008.270
  31. Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803
  32. Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273
  33. Schutte R, 2012, HYPERTENSION, V60, P1138, DOI 10.1161/HYPERTENSIONAHA.112.202143
  34. Parati G, 2008, HYPERTENSION, V52, P1006, DOI 10.1161/HYPERTENSIONAHA.108.115212
  35. Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900
  36. Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1
  37. Turak O, 2014, J CLIN HYPERTENS, V16, P530, DOI 10.1111/jch.12359
  38. Rakugi H, 2015, J HYPERTENS, V33, P2165, DOI 10.1097/HJH.0000000000000668
  39. Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727
  40. KAI H, 1994, HYPERTENSION, V24, P523
  41. Liu ZD, 2013, BLOOD PRESS MONIT, V18, P316, DOI 10.1097/MBP.0000000000000001
  42. Sato N, 2015, CLIN EXP HYPERTENS, V37, P411, DOI 10.3109/10641963.2014.995802
  43. Jacob P, 2004, J HUM HYPERTENS, V18, P745, DOI 10.1038/sj.jhh.1001734
  44. Stergiou GS, 2011, HYPERTENS RES, V34, P1246, DOI 10.1038/hr.2011.145
  45. Takayama N, 2011, HYPERTENS RES, V34, P341, DOI 10.1038/hr.2010.229
  46. Felicio JS, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-36
  47. Parati G, 2010, J HYPERTENS, V28, P2177, DOI 10.1097/HJH.0b013e32833e1150
  48. Filomena J, 2015, HYPERTENSION, V66, P634, DOI 10.1161/HYPERTENSIONAHA.115.05440
  49. Nagai M, 2013, AM J HYPERTENS, V26, P1369, DOI 10.1093/ajh/hpt167
  50. Yasuoka S, 2013, CIRC J, V77, P1474, DOI 10.1253/circj.CJ-12-1253
  51. Chen YJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0059-8
  52. Minutolo R, 2007, AM J KIDNEY DIS, V50, P908, DOI 10.1053/j.ajkd.2007.07.020
  53. Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7
  54. Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62
  55. Lu ZA, 2003, CLIN EXP PHARMACOL P, V30, P49, DOI 10.1046/j.1440-1681.2003.03788.x
  56. Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858
  57. Tao X, 2004, J HYPERTENS, V22, P557, DOI 10.1097/01.hjh.0000098261.58662.B1
  58. Diaz KM, 2014, HYPERTENSION, V64, P965, DOI 10.1161/HYPERTENSIONAHA.114.03903
  59. Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255
  60. Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x
  61. Levi-Marpillat N, 2014, HYPERTENS RES, V37, P585, DOI 10.1038/hr.2014.33
  62. Kario K, 2015, HYPERTENSION, V65, P1163, DOI 10.1161/HYPERTENSIONAHA.115.04800
  63. Yano Y, 2014, HYPERTENSION, V64, P983, DOI 10.1161/HYPERTENSIONAHA.114.03978
  64. Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X
  65. COWLEY AW, 1973, CIRC RES, V32, P564
  66. Hermida RC, 2011, CHRONOBIOL INT, V28, P601, DOI 10.3109/07420528.2011.589935
  67. KRIEGER EM, 1964, CIRC RES, V15, P511
  68. Gironacci MM, 2014, CLIN SCI, V127, P295, DOI 10.1042/CS20130450
  69. James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427
  70. Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x
  71. Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008
  72. Su DF, 2001, CLIN EXP PHARMACOL P, V28, P709, DOI 10.1046/j.1440-1681.2001.03508.x
  73. Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj/jhh/1001301
  74. Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI 10.1161/HYPERTENSIONAHA.109.140798
  75. Kaneda R, 2005, AM J HYPERTENS, V18, P1528, DOI 10.1016/j.amjhyper.2005.06.015
  76. Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126
  77. Parati G, 2014, J HYPERTENS, V32, P1326, DOI 10.1097/HJH.0000000000000169
  78. Chowdhury EK, 2014, J HYPERTENS, V32, P525, DOI 10.1097/HJH.0000000000000028
  79. Ponchon P, 1996, EUR J PHARMACOL, V297, P61, DOI 10.1016/0014-2999(95)00721-0
  80. PARATI G, 1987, J HYPERTENS, V5, P93, DOI 10.1097/00004872-198702000-00013
  81. Webb AJS, 2014, STROKE, V45, P2967, DOI 10.1161/STROKEAHA.114.005982
  82. Umemoto S, 2016, HYPERTENS RES, V39, P46, DOI 10.1038/hr.2015.104
  83. Bertagnolli M, 2014, PEPTIDES, V51, P65, DOI 10.1016/j.peptides.2013.11.006
  84. Kudo H, 2009, HYPERTENSION, V54, P832, DOI 10.1161/HYPERTENSIONAHA.109.135905
  85. Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094
  86. Manios E, 2009, J HYPERTENS, V27, P2244, DOI 10.1097/HJH.0b013e328330a94f
  87. FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019
  88. Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1
  89. Yano Y, 2009, AM J HYPERTENS, V22, P1177, DOI 10.1038/ajh.2009.162
  90. Su DF, 2005, TRENDS PHARMACOL SCI, V26, P388, DOI 10.1016/j.tips.2005.06.003
  91. TIMIO M, 1995, CLIN NEPHROL, V43, P382
  92. Mostarda CT, 2014, J DIABETES COMPLICAT, V28, P273, DOI 10.1016/j.jdiacomp.2013.12.005
  93. Zhang C, 2003, J HYPERTENS, V21, P2141, DOI 10.1097/01.hjh.0000098121.00558.55
  94. Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8
  95. Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007
  96. Tamura K, 2011, HYPERTENS RES, V34, P1249, DOI 10.1038/hr.2011.149
  97. PALATINI P, 1992, ARCH INTERN MED, V152, P1855, DOI 10.1001/archinte.152.9.1855
  98. Lataro RM, 2015, AM J HYPERTENS, V28, P1201, DOI 10.1093/ajh/hpv017
  99. Aoki Y, 2014, CIRC J, V78, P2284, DOI 10.1253/circj.CJ-14-0027
  100. Vishram JKK, 2015, J HYPERTENS, V33, P2422, DOI 10.1097/HJH.0000000000000739
  101. Matsui Y, 2012, HYPERTENSION, V59, P1132, DOI 10.1161/HYPERTENSIONAHA.111.189217
  102. Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539
  103. Asayama K, 2015, HYPERTENS RES, V38, P97, DOI 10.1038/hr.2014.153
  104. Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JC125397
  105. Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001
  106. Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846
  107. Matsui Y, 2011, HYPERTENSION, V57, P1087, DOI 10.1161/HYPERTENSIONAHA.111.171645
  108. Arashi H, 2015, AM J CARDIOL, V116, P236, DOI 10.1016/j.amjcard.2015.04.011
  109. Liu JG, 2003, J HYPERTENS, V21, P1961, DOI 10.1097/01.hjh.0000084762.37215.e7
  110. O'Brien E, 2013, HYPERTENSION, V62, P988, DOI 10.1161/HYPERTENSIONAHA.113.02148
  111. Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B
  112. Neto OB, 2013, J SPORT SCI MED, V12, P52
  113. Bohm M, 2015, HYPERTENSION, V65, P651, DOI 10.1161/HYPERTENSIONAHA.114.04568
  114. Bombelli M, 2014, HYPERTENSION, V64, P943, DOI [10.1161/HYPERTENSIONAHA.114.03675, DOI 10.1161/HYPERTENSIONAHA.114.03675]
  115. Casali KR, 2016, J RENIN ANGIOTENSIN, V17
  116. Du WM, 2003, J CARDIOVASC PHARM, V41, P233
  117. Friberg P, 1982, P 4 INT S RATS SPON, P361
  118. Angelats EG, 2004, MED CLIN-BARCELONA, V123, P731
  119. Juhanoja EP, 2016, J HYPERTENS, V34, P61, DOI 10.1097/HJH.0000000000000772
  120. Karpov Yuri A, 2015, High Blood Press Cardiovasc Prev, V22, P417, DOI 10.1007/s40292-015-0117-0
  121. Madden JM, 2016, HYPERTENS RES, V39, P171, DOI 10.1038/hr.2015.126
  122. Mancia G, 2016, J HYPERTENS, V34, P139, DOI 10.1097/HJH.0000000000000767
  123. Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927
  124. Miao CY, 2000, ACAD J 2 MILITARY ME, V21, P734
  125. Moreira ED, 2013, PHYSL REP, V1, DOI 10.1002/phy2.45
  126. Ryu J, 2014, J KOREAN MED SCI, V29, P957, DOI 10.3346/jkms.2014.29.7.957
  127. Shiga Yuhei, 2015, J Clin Med Res, V7, P802, DOI 10.14740/jocmr2292w
  128. Sirvente RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087935
  129. Song HB, 2015, CLIN EXP HYPERTENS, V37, P63, DOI 10.3109/10641963.2014.897724
  130. Wijsman LW, 2015, AM J HYPERTENS, DOI [10.1093/ajh/hpv101, DOI 10.1093/AJH/HPV101]

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/59